Cardiology (all articles)
#ESCCongress – [Abstract Only] SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: A meta-analysis of the EMPEROR-Reduced and DAPA-HF trials
31 Aug, 2020 | 01:36h | UTC
#ESCCongress – Initial invasive versus conservative management of stable ischemic heart disease patients with a history of heart failure or left ventricular dysfunction: Insights from the ISCHEMIA Trial
31 Aug, 2020 | 01:30h | UTC
Commentary on Twitter
ISCHEMIA Trial: In patients w/ischemia & CHF (LVEF 35-45%), an early invasive strategy might improve event-free survival #CircESC20 #ESCCongress #AHAJournals @RenatoDLopes1 @DCRINews @DukeHeartCenter @AHAScience https://t.co/G5FDD7ipL9 pic.twitter.com/joYIxGx544
— Circulation (@CircAHA) August 29, 2020
#ESCCongress – [Abstract Only] Randomized trial: Low-dose edoxaban in very elderly patients with atrial fibrillation
31 Aug, 2020 | 01:32h | UTCCommentaries: Edoxaban Low-Dose for Elder Care Atrial Fibrillation – ELDERCARE-AF – American College of Cardiology AND ELDERCARE-AF: Edoxaban Superior to Placebo in Preventing Stroke, Systemic Embolism in Elderly Japanese AFib Patients – American College of Cardiology
Commentary on Twitter
Elderly patients with AF who were not candidates for standard doses of oral anticoagulants because of a high risk of bleeding were assigned to receive 15 mg of edoxaban or placebo once daily. Edoxaban was superior to placebo in preventing stroke or systemic embolism. #ESCCongress
— NEJM (@NEJM) August 30, 2020
#ESCCongress – Randomized trial: Colchicine not beneficial for patients with acute coronary syndrome
31 Aug, 2020 | 01:26h | UTCCommentaries: Colchicine to Improve Cardiovascular Outcomes in ACS Patients – COPS – Circulation
Commentary on Twitter
Colchicine in Patients with Acute Coronary Syndrome: The Australian COPS RCT vs COLCOT RCT #ESCCongress 🔴 seemingly opposite results, dose start time patients? @almucastro01 @ValleAlfonso @JoseJuanatey @Dr_Manito @secardiologia @varrarte @sociedadSEEN 🤔🩺https://t.co/uagW2HRGPt pic.twitter.com/SQoVsbzG0m
— Oscar Moreno # (@moreno_perez_o) August 30, 2020
#ESCCongress – Time-to-treatment initiation of colchicine and cardiovascular outcomes after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT)
31 Aug, 2020 | 01:23h | UTCCommentary: Colchicine Cardiovascular Outcomes Trial – COLCOT – American College of Cardiology
Commentary on Twitter
#ESCCongress #COLCOT Study looking at TTI colchicine to assess if timing impacted outcomes
❤️ACS treatment with colchicine 🆚 placebo: 23%⤵️ in events
❤️Randomized w/in 30days postMI
🔺TTI (Time to Treat Initiation) 0-3d 🆚 4-7d 🆚 8-30d
🔺0-3 days had better outcomes pic.twitter.com/iQAkts1BG9— Dr. Martha Gulati ♥️🫀❤️🩹🇨🇦 (@DrMarthaGulati) August 30, 2020
#ESCCongress – [Abstract Only] Randomized trial: Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy
31 Aug, 2020 | 01:21h | UTCCommentary: EXPLORER-HCM: Mavacamten Improves Exercise Capacity and Functional Class – TCTMD
Commentary on Twitter
Latebreaking now at #ESCCongress—Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial https://t.co/JcJnGI0VVt pic.twitter.com/Xmf98Bcoir
— The Lancet (@TheLancet) August 29, 2020
#ESCCongress – 2020 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation
31 Aug, 2020 | 01:20h | UTCNews Release: How to treat the most common heart attacks – European Society of Cardiology
Commentary: 2020 ESC NSTE-ACS Guidelines: Key Points – American College of Cardiology
Commentary on Twitter
ESC 2020 Guidelines for non-ST elevation acute coronary syndrome just released https://t.co/dKIngRO59K#ESCCongress #ESCGuidelines #cardiotwitter #MedTwitter pic.twitter.com/ihcnxcCzBw
— European Society of Cardiology (@escardio) August 29, 2020
#ESCCongress – 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation
31 Aug, 2020 | 01:18h | UTCNews Release: Heart rhythm disorders are best managed when patients are listened to – European Society of Cardiology
Commentary on Twitter
2020 ESC Guidelines for diagnosis & management of atrial fibrillation https://t.co/SSuQAr13TO#ESCCongress @escardio @ESC_Journals @AChoiHeart @purviparwani @DrMarthaGulati @ErinMichos @DrPascalMeier pic.twitter.com/5cLRSJbldp
— Open Heart (@Open_HeartBMJ) August 29, 2020
#ESCCongress – ESC Position statement: Recommendations for participation in competitive sport in adolescent and adult athletes with Congenital Heart Disease
31 Aug, 2020 | 01:14h | UTC
#ESCCongress – 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease
31 Aug, 2020 | 01:16h | UTCNews Release: Can people with heart disease exercise safely? – European Society of Cardiology
Commentary on Twitter
Finally out. ESC sports cardiology guidelines for exercise in patients with cardiovascular disease.https://t.co/1hLbhfLdIb @s_gati @MichaelPapadak2 @StGeorgesUni @DrAneilMalhotra @DrSarahClarke @SilCastelletti @DrTiberi @DreznerJon @TJ_Yeo @CSHeartResearch #ESCCongress pic.twitter.com/JIrgPLaKQY
— Sanjay Sharma (@SSharmacardio) August 29, 2020
#ESCCongress – 2020 ESC Guidelines for the management of adult congenital heart disease
31 Aug, 2020 | 01:13h | UTCNews Release: What happens when babies with heart defects become adults? – European Society of Cardiology
Commentary on Twitter
2020 ESC Guidelines for management of adult congenital heart diseasehttps://t.co/MPHMJ2KKIc#ESCCongress #ACHD #CardioTwitter #ESCGuidelines @ErinMichos @DrMarthaGulati @ddefariayeh @AmiBhattMD @FredWuMD @anudodejamd pic.twitter.com/4LrrnAAxZ1
— Open Heart (@Open_HeartBMJ) August 29, 2020
Meta-analysis: Association of cardiovascular disease and 10 other pre-existing comorbidities with COVID-19 mortality
28 Aug, 2020 | 08:45h | UTC
AHA Scientific Statement: Considerations for reduction of risk of perioperative stroke in adult patients undergoing cardiac and thoracic aortic operations
27 Aug, 2020 | 09:46h | UTCNews Release: Steps outlined to reduce the risk of stroke during, after heart surgery – American Heart Association
Top Things to Know: Considerations for Reduction of Risk of Perioperative Stroke in Adult Patients Undergoing Cardiac and Thoracic Aortic Operations
Commentary: Teamwork Needed to Reduce Stroke and Its Consequences in Cardiac Surgery: AHA – TCTMD
Systematic review: Effect of renin-angiotensin-aldosterone system inhibitors in patients with COVID-19
26 Aug, 2020 | 04:05h | UTCCommentaries: Expert reaction to study looking at blood pressure medicines and COVID-19 – Science Media Centre AND Coronavirus Treatment: Blood Pressure Medicines May Reduce COVID-19 Severity, Deaths: Study – International Business Times
Podcast: Hypertension in the Hospital
25 Aug, 2020 | 03:38h | UTCAnnals On Call – Hypertension in the Hospital – Annals of Internal Medicine
Commentary on Twitter
Listen to the latest #AnnalsOnCall with @medrants, Dr Timothy Anderson, and @WrayCharles on #Hypertension in the Hospital https://t.co/OouHuYg0wt. pic.twitter.com/CbJyq7wyDq
— Annals of Int Med (@AnnalsofIM) August 24, 2020
Observational study: Revascularization practices and outcomes in patients with multivessel coronary artery disease who presented with acute myocardial infarction and cardiogenic shock
25 Aug, 2020 | 03:42h | UTCRevascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018 – JAMA Internal Medicine (free for a limited period)
Editorial: Multivessel or Culprit Vessel–Only Percutaneous Coronary Intervention for Patients With Acute Myocardial Infarction and Cardiogenic Shock: Real-World Evidence in Support of CULPRIT-SHOCK (free for a limited period)
Commentaries: Multivessel PCI Associated With Higher In-Hospital Mortality Compared With Culprit-Vessel PCI, NCDR Study Finds – American College of Cardiology AND Less aggressive treatment better for heart patients who go into shock – Yale University
Related Research: PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock – New England Journal of Medicine AND One-Year Outcomes after PCI Strategies in Cardiogenic Shock – New England Journal of Medicine
Commentary on Twitter (Thread – Click for more)
In @JAMAInternalMed is our evaluation of revascularization practices in AMI w shock
In 2017, CULPRIT-SHOCK found harm w MV-PCI in MV-CAD – in the decade preceding it, MV-PCI was an increasingly popular strategy.
🧵below
w/ @rwyeh @ACCinTouch https://t.co/xz0HHnvhNU pic.twitter.com/DWaVXG8vcU
— Rohan Khera (@rohan_khera) August 24, 2020
Case report: SARS-CoV-2 in cardiac tissue of a child with COVID-19-related multisystem inflammatory syndrome
24 Aug, 2020 | 00:38h | UTC
Commentary on Twitter
Presence of #SARSCoV2 in heart muscle and endocardial cells in an 11-year-old girl who died of cardiac complications from #COVID19. It's the 1st report of child affected by MIS-C w/ documented presence of viral particles in the hearthttps://t.co/70M8BYaQGy pic.twitter.com/5aHDtpO8SZ
— Eric Topol (@EricTopol) August 20, 2020
Imaging assessment of mitral and aortic regurgitation: Current state of the art
24 Aug, 2020 | 00:26h | UTCImaging assessment of mitral and aortic regurgitation: current state of the art – Heart
COVID-19 and cardiac arrhythmias
21 Aug, 2020 | 02:29h | UTCCOVID-19 Infection and Cardiac Arrhythmias – Trends in Cardiovascular Medicine
Management and outcomes of patients with STEMI during the COVID-19 pandemic in China
21 Aug, 2020 | 02:28h | UTC
Non-cardiac surgery in patients with coronary artery disease: Risk evaluation and periprocedural management
21 Aug, 2020 | 02:23h | UTC
NICE Guideline: Perioperative care in adults
20 Aug, 2020 | 09:17h | UTCPerioperative care in adults – National Institute for Health and Care Excellence
Commentary on Twitter
https://t.co/1aHU3TroSp
NICE published its periop care guidelines today. Rather than being a compendium of periop medicine, it provides guidance on how the care can be improved, and should be welcomed by all periop HCPs pic.twitter.com/qlPifdUZll— Nicholas Levy (@nicholasalevy) August 19, 2020
Meta-analysis: Use of inhibitors of the renin‐angiotensin system in hypertensive patients and COVID‐19 severity
19 Aug, 2020 | 09:35h | UTC
Review: Infective endocarditis after surgical and transcatheter aortic valve replacement
19 Aug, 2020 | 09:23h | UTC
Opinion: Covid-19 is creating a wave of heart disease
18 Aug, 2020 | 07:43h | UTCCovid-19 Is Creating a Wave of Heart Disease – The New York Times
Related: Covid-19 Can Cause Heart Damage—Even If You Are Asymptomatic – Forbes